Grade My Investments
HomeFree Stock Grades › PDEX

Pro-Dex, Inc. (PDEX) Stock Grade

PDEX · Healthcare

A+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$143.5M
P/E Ratio
16.0
Revenue Growth (YoY)
+23.7%
Net Margin
13.5%
Return on Equity
24.5%
Dividend Yield
None

About Pro-Dex, Inc.'s fundamentals

Pro-Dex is a small-cap medical instruments company with a market capitalization of $143.5 million that is experiencing strong revenue growth of 23.7% year-over-year. The company maintains a healthy net profit margin of 13.5% and generates an impressive return on equity of 24.5%, indicating efficient use of shareholder capital. Trading at a P/E ratio of 16.0, the company does not currently pay a dividend, reinvesting earnings back into the business.

Track PDEX free — no credit card required. Live grade + monthly AI report →